Cambridge Cognition Holdings Plc (AIM:COG)
London flag London · Delayed Price · Currency is GBP · Price in GBX
37.50
-1.17 (-3.12%)
Jun 17, 2025, 4:35 PM GMT+1

Cambridge Cognition Holdings Company Description

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally.

The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints.

It also provides electronic questionnaires and scales (eCOA), which collect neurocognitive data in a data capture system; the automated quality assurance (AQUA) solution, which analyzes the audio during the administration of central nervous system (CNS) clinical scales to detect deviations in administration and scoring; and Clinpal, a decentralized clinical trials platform.

Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.

Cambridge Cognition Holdings Plc
Country United Kingdom
Founded 2012
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 84
CEO Matthew Stork

Contact Details

Address:
Tunbridge Court
Cambridge, CB25 9TU
United Kingdom
Website cambridgecognition.com

Stock Details

Ticker Symbol COG
Exchange London Stock Exchange AIM
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB00B8DV9647
SIC Code 8200

Key Executives

Name Position
Matthew Stork Chief Executive Officer